John Donofrio Jr.
CIK: 0001679841
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AYTU
AYTU BIOPHARMA, INC
Director
Discretionary Trading P&L
Holdings
About Donofrio John Jr.
Donofrio John Jr. (SEC CIK 0001679841) files insider reports with the SEC as Director of AYTU BIOPHARMA, INC (AYTU).
Signal8 holds 3 ownership filings by Donofrio John Jr., all Form 4s, filed between Nov 8, 2024 and Jul 30, 2026. Those filings report 3 transactions, from Nov 6, 2024 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Donofrio John Jr.'s filings is in DENVER, CO.
Recent filings by Donofrio John Jr.
Other insiders filing for AYTU BIOPHARMA, INC (AYTU)
- Disbrow Joshua R., Chief Executive Officer
- PYSZCZYMUKA GREG, Chief Commercial Officer
- Disbrow Jarrett, Chief Business Officer
- Selhorn Ryan J, Chief Financial Officer
- LIU VIVIAN H, Director
- JAIN ABHINAV, Director